Quick Takeaways
- Christopher B. Prentiss has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $830,363.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Christopher B. Prentiss and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MNKD | MANNKIND CORP | Chief Financial Officer | $830,363 | 22 Apr 2026 | ||
| ADMS | Adamas Pharmaceuticals Inc | Chief Financial Officer | 24 Nov 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|